Cargando…

New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease

BACKGROUND: Amyloid precursor protein (APP), a key molecule in Alzheimer’s disease (AD), is metabolized in two alternative cleavages, generating either the amyloidogenic peptides involved in AD pathology or the soluble form of APP (sAPPα). The level of amyloidogenic peptides in human cerebrospinal f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rose, Christiane, Peoc’h, Katell, Chasseigneaux, Stéphanie, Paquet, Claire, Dumurgier, Julien, Bourasset, Fanchon, Calon, Frédéric, Laplanche, Jean-Louis, Hugon, Jacques, Allinquant, Bernadette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Methodology Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418197/ https://www.ncbi.nlm.nih.gov/pubmed/22824057 http://dx.doi.org/10.1186/1471-2202-13-84

Ejemplares similares

Secreted Amyloid Precursor Protein β and Secreted Amyloid Precursor Protein α Induce Axon Outgrowth In Vitro through Egr1 Signaling Pathway
por: Chasseigneaux, Stéphanie, et al.
Publicado: (2011)

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
por: Dumurgier, Julien, et al.
Publicado: (2015)

PAT1 inversely regulates the surface Amyloid Precursor Protein level in mouse primary neurons
por: Dilsizoglu Senol, Aysegul, et al.
Publicado: (2015)

Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A
por: Chasseigneaux, Stéphanie, et al.
Publicado: (2014)

Expression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-β peptide
por: Dodacki, Agnès, et al.
Publicado: (2017)

Iron deficiency markers in patients undergoing iron replacement therapy: a 9-year retrospective real-world evidence study using healthcare databases
por: Cacoub, Patrice, et al.
Publicado: (2020)

Genotyping Test with Clinical Factors: Better Management of Acute Postoperative Pain?
por: Hajj, Aline, et al.
Publicado: (2015)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
por: Boumenir, Adla, et al.
Publicado: (2019)

Ferroptosis in Liver Diseases: An Overview
por: Capelletti, Martina Maria, et al.
Publicado: (2020)

Iron Metabolism in Normal and Pathological Pregnancies and Fetal Consequences
por: Mégier, Charles, et al.
Publicado: (2022)

Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease
por: Dumurgier, Julien, et al.
Publicado: (2013)

Biomarker profiles of Alzheimer’s disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau
por: Lafirdeen, Aysha S. Mohamed, et al.
Publicado: (2019)

Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?—a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools
por: Mégarbane, Bruno, et al.
Publicado: (2021)

Epidemiokinetic Tools to Monitor Lockdown Efficacy and Estimate the Duration Adequate to Control SARS-CoV-2 Spread
por: Mégarbane, Bruno, et al.
Publicado: (2021)

Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses
por: Mégarbane, Bruno, et al.
Publicado: (2021)

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
por: Lehmann, Sylvain, et al.
Publicado: (2014)

Smoking Related Diseases: The Central Role of Monoamine Oxidase
por: Rendu, Francine, et al.
Publicado: (2011)

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer’s Disease
por: Paquet, Claire, et al.
Publicado: (2015)

Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms
por: Uzzan, Mathieu, et al.
Publicado: (2020)

Reversible atransferrinemia in a patient with chronic enteropathy: is transferrin mandatory for iron transport?
por: Raynor, Alexandre, et al.
Publicado: (2022)

Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top–Down Proteomics: A Pilot Study
por: Molinari, Nicolas, et al.
Publicado: (2018)

PKR downregulation prevents neurodegeneration and β-amyloid production in a thiamine-deficient model
por: Mouton-Liger, F, et al.
Publicado: (2015)

Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
por: Lehmann, Sylvain, et al.
Publicado: (2023)

PKR involvement in Alzheimer’s disease
por: Hugon, Jacques, et al.
Publicado: (2017)

Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function
por: Delay, Charlotte, et al.
Publicado: (2011)

617. Efficacy of Dimercaptosuccinic Acid (DMSA), a Zinc Chelator, in Combination with Imipenem Against Metallo-β-Lactamase Producing Escherichia coli in a Murine Peritonitis Model
por: Cheminet, Geoffrey, et al.
Publicado: (2019)

Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients
por: Touzot, Maxime, et al.
Publicado: (2021)

Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency
por: Manceau, Hana, et al.
Publicado: (2022)

Blood-Based Kinase Assessments in Alzheimer’s Disease
por: Hugon, Jacques, et al.
Publicado: (2018)

Early care of N-acetyl glutamate synthase (NAGS) deficiency in three infants from an inbred family
por: Peoc'h, Katell, et al.
Publicado: (2020)

Circulating Apolipoprotein B-48 as a Biomarker of Parenteral Nutrition Dependence in Adult Patients with Short Bowel Syndrome
por: Fourati, Salma, et al.
Publicado: (2023)

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease
por: Perneczky, R, et al.
Publicado: (2013)

Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial
por: Lasocki, Sigismond, et al.
Publicado: (2021)

Altered amyloid precursor protein processing regulates glucose uptake and oxidation in cultured rodent myotubes
por: Hamilton, D. Lee, et al.
Publicado: (2014)

Smoking Induces Long-Lasting Effects through a Monoamine-Oxidase Epigenetic Regulation
por: Launay, Jean-Marie, et al.
Publicado: (2009)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System
por: Dobrowolska, Justyna A., et al.
Publicado: (2014)

Soluble amyloid-β precursor peptide does not regulate GABA(B) receptor activity
por: Rem, Pascal Dominic, et al.
Publicado: (2023)

I-FABP is decreased in COVID-19 patients, independently of the prognosis
por: Guedj, Kevin, et al.
Publicado: (2021)

Amyloid precursor protein and amyloid precursor-like protein 2 in cancer
por: Pandey, Poomy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_df746ekj2q1gubantqja76ou68